2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Software tools for implementing simulation studies in adaptive seamless designs: introducing R package ASD

      abstract
      1 , , 2 , 3 , 1
      Trials
      BioMed Central
      Clinical Trials Methodology Conference 2011
      4-5 October 2011

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Adaptive designs for clinical trials have the potential to improve the efficiency of clinical research by, for instance, seamlessly combining different stages of a clinical development programme. Adaptive seamless designs (ASD) combining phases II and III with adaptations such as treatment or subgroup selection are becoming increasingly widely used. The work required to develop application specific software for each new trial is a potential barrier to the more extensive use of ASD, particularly as simulation studies are often required at the planning stage to explore a range of options prior to deciding on an appropriate design. A number of common analysis methods (e.g. weighted inverse normal combination functions) and simulation tools for assessing the performance of a number of design options, are available in some widely used commercial packages, but currently no free software exists for planning and simulation of ASD. Parsons et al. [1] developed R package asd specifically for undertaking simulations to investigate designs for treatment selection based on early outcomes [2]. The freely available software simulates normal test statistics, rather than individual patient data, in the setting of treatment selection, providing flexibility to deal with combinations of scales (e.g. normal, binary) for both early and final outcomes, for two stage designs. Two examples for normally distributed and binomially distributed final outcomes are described with code demonstrating implementation in the software and output to show how this methodology can be used explore a range of options prior to deciding on an appropriate trial design. The software is flexible and fast, allowing many design options to be explored, and is currently in the process of being extended in a new version that will also include simulations for subpopulation selection. The software is available from the Comprehensive R Archive Network [http://cran.r-project.org/] and more details can be found at the Package Website [http://cran.r-project.org/web/packages/asd/].

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.

          In recent years adaptive seamless phase II/III designs (ASDs) allowing treatment or dose selection at an interim analysis have gained much attention because of their potential to save development costs and to shorten time-to-market of a new compound compared to conventional drug development programmes with separate trials for individual phases. In this paper, we describe an ASD with treatment selection based on early outcome data, specifically considering the situation where no final outcomes are observed at the time of the interim analysis. Bringing together combination tests for adaptive designs and the closure principle for multiple testing, control of the familywise type I error rate in the strong sense is achieved. Furthermore, a simulation model is proposed based on standardized test statistics that allows the generation of virtual trials for a variety of outcomes. We use this simulation model to investigate the actual type I error rate of the proposed testing procedure and find that the familywise type I error rate is controlled as expected. The method is often conservative, with the degree of conservatism depending on the correlation between early and late outcome, the true mean values of the early outcome in the different treatment groups and the selection rule. The investigations are motivated and illustrated by an application of the proposed design and simulation model to progressive multiple sclerosis. Copyright © 2011 John Wiley & Sons, Ltd.
            Bookmark

            Author and article information

            Conference
            Trials
            Trials
            BioMed Central
            1745-6215
            2011
            13 December 2011
            : 12
            : Suppl 1
            : A8
            Affiliations
            [1 ]Warwick Medical School, The University of Warwick, Coventry, UK
            [2 ]University Medical Center Göttingen, Göttingen, Germany
            [3 ]Applied Statistics, University of Reading, Reading, UK
            Article
            1745-6215-12-S1-A8
            10.1186/1745-6215-12-S1-A8
            3287799
            c019f27c-0acb-4fa4-bdae-c50613bf708c
            Copyright ©2011 Parsons et al; licensee BioMed Central Ltd.

            This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            Clinical Trials Methodology Conference 2011
            Bristol, UK
            4-5 October 2011
            History
            Categories
            Poster Presentation

            Medicine
            Medicine

            Comments

            Comment on this article